A bad start to the year for K'netha Faggart, a mother living in Concord in the US state of North Carolina, who thought she'd ...
Oculis' main value driver appears to be OCS-01, which targets a respectable $4B DME TAM with its non-invasive eye drops. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback